Palantir, whose IPO was one of the most anticipated of the year, reported sales rose 25% in 2019 to $742.6 million, with a net loss that narrowed slightly from $580 million to $579.6 million; it applied to list on the New York Stock Exchange under ticker symbol “PLTR” and filed to go public via a direct listing, meaning it will not raise new capital.
